4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Personalis, Inc. (PSNL) operates in the Diagnostics & Research industry and is headquartered in Fremont, United States with about 259 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PSNL reported $70M in revenue and ($81M) in net income.
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Interactive charts & full statements → Open the PSNL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $70M | $85M | $74M | $65M | — |
| Gross Profit | $16M | $27M | $18M | $13M | — |
| Operating Income (EBIT) | ($88M) | ($68M) | ($96M) | ($116M) | — |
| Net Income | ($81M) | ($81M) | ($108M) | ($113M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $16M | $17M | $14M | $17M | $21M | — |
| Gross Profit | $0M | $2M | $2M | $5M | $7M | — |
| Operating Income (EBIT) | ($32M) | ($25M) | ($23M) | ($22M) | ($18M) | — |
| Net Income | ($30M) | ($24M) | ($22M) | ($20M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $334M | $270M | $225M | $293M | — |
| Total Liabilities | $73M | $67M | $96M | $75M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PSNL viewer.
About TickerBase · Data methodology & sources